Gilead Sciences
The latest news about Gilead Sciences: headlines, AI summaries and the full story from every source.
- Morgan Stanley Maintains Positive Outlook on Gilead Sciences, Highlighting HIV Prevention Franchise
- Gilead Expands HIV Drug Access to Latin America via PAHO Agreement
- Gilead Sciences' Stock Performance Compared to Other Healthcare Stocks
- Gilead Sciences Reports Positive Long-Term Data for Livdelzi and Receives EMA Support for Trodelvy
- Gilead Sciences Announces New Results From a Post Hoc Analysis of Livdelzi in Primary Biliary Cholangitis
- Gilead Sciences (GILD) Receives Bullish Analyst Rating Amid Strong Financial Performance
- Arcus Biosciences Halts Late-Stage Trial of Anti-TIGIT Therapy in Collaboration with Gilead Sciences
- Citi Increases Price Target for Gilead Sciences Ahead of Q1 Biopharma Outlook